Stock Analysis

Ambu Full Year 2022 Earnings: Revenues In Line With Expectations

  •  Updated
CPSE:AMBU B
Source: Shutterstock

Ambu (CPH:AMBU B) Full Year 2022 Results

Key Financial Results

  • Revenue: kr.4.44b (up 11% from FY 2021).
  • Net income: kr.93.0m (down 62% from FY 2021).
  • Profit margin: 2.1% (down from 6.2% in FY 2021).
earnings-and-revenue-growth
CPSE:AMBU B Earnings and Revenue Growth November 17th 2022

All figures shown in the chart above are for the trailing 12 month (TTM) period

Ambu Meets Expectations

Revenue was in line with analyst estimates.

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Medical Equipment industry in Denmark.

Performance of the Danish Medical Equipment industry.

The company's shares are down 18% from a week ago.

Risk Analysis

It is worth noting though that we have found 3 warning signs for Ambu that you need to take into consideration.

Valuation is complex, but we're helping make it simple.

Find out whether Ambu is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis